| scholarly article | Q13442814 |
| P50 | author | Shuji Ogino | Q18055035 |
| David J. Hunter | Q21066148 | ||
| Eva Schernhammer | Q62586412 | ||
| Charles S. Fuchs | Q88762246 | ||
| Katsuhiko Nosho | Q113460216 | ||
| P2093 | author name string | Kaori Shima | |
| Natsumi Irahara | |||
| Yoshifumi Baba | |||
| Neal I Lindeman | |||
| Aditi Hazra | |||
| P2860 | cites work | Bisulfite genomic sequencing: systematic investigation of critical experimental parameters | Q24555629 |
| Analysis of repetitive element DNA methylation by MethyLight | Q24814952 | ||
| Pyrosequencing sheds light on DNA sequencing | Q28142599 | ||
| Global loss of imprinting leads to widespread tumorigenesis in adult mice | Q40361864 | ||
| Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells | Q40365867 | ||
| A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements | Q40587967 | ||
| Mutation detection by pyrosequencing: sequencing of exons 5-8 of the p53 tumor suppressor gene | Q40752736 | ||
| DNA demethylation and pericentromeric rearrangements of chromosome 1. | Q41087672 | ||
| Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis | Q42738436 | ||
| The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer | Q46073818 | ||
| Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage | Q46846179 | ||
| Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. | Q53364219 | ||
| Analysis of the p53 tumor suppressor gene by pyrosequencing | Q73389959 | ||
| LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer | Q81459025 | ||
| Gene-specific methylation and subsequent risk of colorectal adenomas among participants of the polyp prevention trial | Q81748609 | ||
| DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia | Q83364381 | ||
| Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites | Q28187720 | ||
| Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing | Q28187734 | ||
| Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis | Q28217446 | ||
| The epigenomics of cancer | Q28289975 | ||
| Epigenetics in cancer | Q29547853 | ||
| Induction of Tumors in Mice by Genomic Hypomethylation | Q29618551 | ||
| LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability | Q33283510 | ||
| LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors | Q33763848 | ||
| A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers | Q33808550 | ||
| Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer | Q33863925 | ||
| Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer | Q33954716 | ||
| Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis | Q34016094 | ||
| Pyrosequencing: an accurate detection platform for single nucleotide polymorphisms | Q34610271 | ||
| Use of pyrosequencing of 16S rRNA fragments to differentiate between bacteria responsible for neonatal sepsis | Q35789839 | ||
| Sensitive sequencing method for KRAS mutation detection by Pyrosequencing | Q35789986 | ||
| Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis | Q35790157 | ||
| CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations | Q35807863 | ||
| The CpG island methylator phenotype in colorectal cancer | Q35855462 | ||
| Rapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample pools | Q35988103 | ||
| A new dimethyl sulfoxide-based method for gene promoter methylation detection | Q36103447 | ||
| Transposons reanimated in mice | Q36226903 | ||
| Locked nucleic acids can enhance the analytical performance of quantitative methylation-specific polymerase chain reaction | Q36329305 | ||
| Array-based multiplex analysis of DNA methylation in breast cancer tissues | Q36329331 | ||
| Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women | Q36398297 | ||
| PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations. | Q36661711 | ||
| Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma. | Q36734626 | ||
| Methylation-specific multiplex ligation-dependent probe amplification enables a rapid and reliable distinction between male FMR1 premutation and full-mutation alleles | Q36944246 | ||
| Differential methylation profile of ovarian cancer in tissues and plasma | Q37024691 | ||
| LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. | Q37070832 | ||
| A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer | Q37090752 | ||
| High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis | Q37151097 | ||
| CpG methylation analysis--current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular Pathology. | Q37261842 | ||
| Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. | Q37266816 | ||
| Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer | Q40327101 | ||
| P433 | issue | 2 | |
| P921 | main subject | pyrosequencing | Q2342248 |
| colon cancer | Q18555025 | ||
| P304 | page(s) | 177-183 | |
| P577 | publication date | 2010-01-21 | |
| P1433 | published in | The Journal of Molecular Diagnostics | Q7743603 |
| P1476 | title | Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells | |
| P478 | volume | 12 |
| Q34438078 | A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer |
| Q34061399 | A method to evaluate genome-wide methylation in archival formalin-fixed, paraffin-embedded ovarian epithelial cells |
| Q34113164 | A refined, rapid and reproducible high resolution melt (HRM)-based method suitable for quantification of global LINE-1 repetitive element methylation |
| Q53278362 | ALU and LINE-1 hypomethylations in multistep gastric carcinogenesis and their prognostic implications. |
| Q61799565 | Aberrant DNA methylation of M1-macrophage genes in coronary artery disease |
| Q90208674 | An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer |
| Q37094281 | Aspirin use and risk of colorectal cancer according to BRAF mutation status |
| Q28277824 | Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival |
| Q28262150 | Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum |
| Q34921255 | Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer |
| Q36765739 | Associations and prognostic implications of Eastern Cooperative Oncology Group performance status and tumoral LINE-1 methylation status in stage III colon cancer patients |
| Q33808553 | Biomarker correlation network in colorectal carcinoma by tumor anatomic location |
| Q35583180 | Cancer immunology--analysis of host and tumor factors for personalized medicine |
| Q34292820 | Cathepsin B expression and survival in colon cancer: implications for molecular detection of neoplasia |
| Q38664513 | Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis |
| Q38154781 | Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer |
| Q47726644 | Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level |
| Q38091024 | DNA methylation and cancer development: molecular mechanism |
| Q33634174 | DNA methylation in the rectal mucosa is associated with crypt proliferation and fecal short-chain fatty acids. |
| Q38709236 | Distinct DNA methylation profiles in bone and blood of osteoporotic and healthy postmenopausal women |
| Q58802796 | Effect of abnormal GpG methylation in the second trimester of pregnancy on adverse health risk of offspring |
| Q37385238 | Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer. |
| Q33942280 | Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors |
| Q35956384 | Fusobacterium nucleatum and T Cells in Colorectal Carcinoma |
| Q39217446 | Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location |
| Q40603067 | Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis |
| Q50420634 | Genetic mechanisms of immune evasion in colorectal cancer. |
| Q37126083 | Genome-wide DNA methylation profiling with MeDIP-seq using archived dried blood spots |
| Q37537553 | Global DNA methylation and one-carbon metabolism gene polymorphisms and the risk of breast cancer in the Sister Study. |
| Q42712173 | Global and MGMT promoter hypomethylation independently associated with genomic instability of lymphocytes in subjects exposed to high-dose polycyclic aromatic hydrocarbon. |
| Q34372543 | Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis |
| Q35026750 | Impact of tissue processing, archiving and enrichment techniques on DNA methylation yield in rectal carcinoma. |
| Q37609842 | Improved results of LINE-1 methylation analysis in formalin-fixed, paraffin-embedded tissues with the application of a heating step during the DNA extraction process |
| Q36733283 | Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer. |
| Q92895821 | Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas |
| Q34167124 | Interpretation of genome-wide infinium methylation data from ligated DNA in formalin-fixed, paraffin-embedded paired tumor and normal tissue |
| Q40064607 | LINE-1 hypermethylation in white blood cell DNA is associated with high-grade cervical intraepithelial neoplasia. |
| Q33886421 | LINE-1 hypomethylation during primary colon cancer progression |
| Q54302136 | LINE-1 hypomethylation in noncancerous esophageal mucosae is associated with smoking history. |
| Q55009932 | LINE-1 hypomethylation is inversely correlated with UHRF1 overexpression in gastric cancer. |
| Q33881018 | LINE-1 hypomethylation is not a common event in preneoplastic stages of gastric carcinogenesis |
| Q37692550 | LINE-1 is preferentially hypomethylated within adenomatous polyps in the presence of synchronous colorectal cancer |
| Q36298764 | LINE-1 methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes |
| Q41699788 | LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas |
| Q39325725 | LINE-1 methylation level and prognosis in pancreas cancer: pyrosequencing technology and literature review |
| Q36001900 | Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications |
| Q34474525 | Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma |
| Q35755035 | MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers |
| Q38939839 | MUC5AC hypomethylation is a predictor of microsatellite instability independently of clinical factors associated with colorectal cancer |
| Q34412558 | Measurements of DNA methylation at seven loci in various tissues of CD1 mice |
| Q33775120 | Methylation Levels of LINE-1 As a Useful Marker for Venous Invasion in Both FFPE and Frozen Tumor Tissues of Gastric Cancer |
| Q37040644 | Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer |
| Q40864425 | MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival. |
| Q36436728 | MicroRNA MIR21 and T Cells in Colorectal Cancer |
| Q39294187 | MicroRNA let-7, T Cells, and Patient Survival in Colorectal Cancer |
| Q37075412 | Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication |
| Q41438298 | Microsatellite instability in gallbladder carcinoma |
| Q24289344 | Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease |
| Q36059870 | No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections. |
| Q37962579 | Novel DNA binding domain-based assays for detection of methylated and nonmethylated DNA. |
| Q33723499 | PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. |
| Q34970844 | Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers |
| Q91646491 | Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells |
| Q36926941 | Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer |
| Q36223053 | Postdiagnostic intake of one-carbon nutrients and alcohol in relation to colorectal cancer survival. |
| Q34234728 | Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies |
| Q24289005 | Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review |
| Q35137525 | Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma |
| Q34250109 | Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer |
| Q34217637 | Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review. |
| Q55381984 | Prognostic value of LINE-1 methylation level in 321 patients with primary liver cancer including hepatocellular carcinoma and intrahepatic cholangiocarcinoma. |
| Q36535688 | Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level |
| Q35124821 | Quantitative gene analysis of methylation and expression (Q-GAME) in fresh or fixed cells and tissues |
| Q41420061 | Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosae |
| Q34796500 | STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers |
| Q35916111 | Sensitive quantitative analysis of murine LINE1 DNA methylation using high resolution melt analysis. |
| Q41303545 | Somatically Acquired LINE-1 Insertions in Normal Esophagus Undergo Clonal Expansion in Esophageal Squamous Cell Carcinoma |
| Q36761405 | Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers |
| Q36563705 | Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer. |
| Q33793560 | Systematic cross-validation of 454 sequencing and pyrosequencing for the exact quantification of DNA methylation patterns with single CpG resolution |
| Q24288715 | TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers |
| Q33784509 | The prognostic significance of whole blood global and specific DNA methylation levels in gastric adenocarcinoma |
| Q35237505 | The prognostic value of global DNA hypomethylation in cancer: a meta-analysis |
| Q40063743 | Tumor Expression of Calcium Sensing Receptor (CASR) and Colorectal Cancer Survival: Results from the Nurses' Health Study and Health Professionals Follow-Up Study |
| Q37631429 | Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer. |
| Q37688202 | Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival |
| Q34169734 | Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis |
| Q35785657 | Tumor TP53 expression status, body mass index and prognosis in colorectal cancer |
| Q97538994 | Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer |
| Q34551974 | Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review |
| Q37327806 | Validation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma |
| Q31045418 | Why do results conflict regarding the prognostic value of the methylation status in colon cancers? The role of the preservation method |
Search more.